Abstract
Patients with normal coagulation function and platelets often present with increased bleeding. These disorders can be acquired or inherited with varying degrees of bleeding diatheses. While detailed history can sometimes provide clues, these patients present a diagnostic challenge. Therefore, they often undergo an expansive work-up in an attempt to accurately characterize the bleeding disorder, notwithstanding the poor diagnostic yield. In this chapter, we discuss some of the common causes of increased bleeding with normal platelets, prothrombin time, and partial thromboplastin time and a rational approach to their diagnosis.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Acharya S, Bussel JB. Hematologic toxicity of sodium valproate. J Pediatr Hematol Oncol. 2000;22(1):62–5.
Althaus K, Greinacher A. MYH9-related platelet disorders. Semin Thromb Hemost. 2009;35(2):189–203.
Bowman M, Hopman WM, Rapson D, Lillicrap D, James P. The prevalence of symptomatic von Willebrand disease in primary care practice. J Thromb Haemost. 2010;8(1):213–6.
Carpenter SL, Mathew P. Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance. Haemophilia. 2008;14(6):1250–4.
Connor P, Khair K, Liesner R, et al. Stem cell transplantation for children with Glanzmann thrombasthenia. Br J Haematol. 2008;140(5):568–71.
de Abajo FJ, Garcia-Rodriguez LA. Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents. Arch Gen Psychiatry. 2008;65(7):795–803.
Eby C. Pathogenesis and management of bleeding and thrombosis in plasma cell dyscrasias. Br J Haematol. 2009;145(2):151–63.
Escolar G, Cases A, Vinas M, et al. Evaluation of acquired platelet dysfunctions in uremic and cirrhotic patients using the platelet function analyzer (PFA-100): influence of hematocrit elevation. Haematologica. 1999; 84(7):614–9.
Hayward CP, Rivard GE. Quebec platelet disorder. Expert Rev Hematol. 2011;4(2):137–41.
Hsieh L, Nugent D. Factor XIII deficiency. Haemophilia. 2008;14(6):1190–200.
Kanaji S, Kuether EL, Fahs SA, et al. Correction of murine Bernard-Soulier syndrome by lentivirus-mediated gene therapy. Mol Ther. 2012;20(3):625–32.
Labos C, Dasgupta K, Nedjar H, Turecki G, Rahme E. Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction. CMAJ. 2011;183(16):1835–43.
Lanza F. Bernard-Soulier syndrome (hemorrhagiparous thrombocytic dystrophy). Orphanet J Rare Dis. 2006;1:46.
Locatelli F, Rossi G, Balduini C. Hematopoietic stem-cell transplantation for the Bernard-Soulier syndrome. Ann Intern Med. 2003;138(1):79.
Lovejoy AE, Reynolds TC, Visich JE, et al. Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency. Blood. 2006;108(1):57–62.
Mehta R, Shapiro AD. Plasminogen deficiency. Haemophilia. 2008;14(6):1261–8.
Nourbakhsh E, Anvari R, D’Cunha N, Thaxton L, Malik A, Nugent K. Postoperative bleeding in a patient with normal screening coagulation tests. Am J Med Sci. 2011;342(3):262–4.
Nurden A, Nurden P. Advances in our understanding of the molecular basis of disorders of platelet function. J Thromb Haemost. 2011;9 Suppl 1:76–91.
Nurden AT, Freson K, Seligsohn U. Inherited platelet disorders. Haemophilia. 2012;18 Suppl 4:154–60.
Paterson AD, Rommens JM, Bharaj B, et al. Persons with Quebec platelet disorder have a tandem duplication of PLAU, the urokinase plasminogen activator gene. Blood. 2010;115(6):1264–6.
Quiroga T, Goycoolea M, Panes O, et al. High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls. Haematologica. 2007;92(3):357–65.
Rydz N, James PD. Why is my patient bleeding or bruising? Hematol Oncol Clin North Am. 2012;26(2):321–44. viii.
Serebruany VL, Glassman AH, Malinin AI, et al. Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) platelet substudy. Circulation. 2003;108(8):939–44.
Stanger MJ, Thompson LA, Young AJ, Lieberman HR. Anticoagulant activity of select dietary supplements. Nutr Rev. 2012;70(2):107–17.
Suzuki J, Umeda M, Sims PJ, Nagata S. Calcium-dependent phospholipid scrambling by TMEM16F. Nature. 2010;468(7325):834–8.
Weigert AL, Schafer AI. Uremic bleeding: pathogenesis and therapy. Am J Med Sci. 1998;316(2):94–104.
White JG. Medich giant platelet disorder: a unique alpha granule deficiency I. Structural abnormalities. Platelets. 2004;15(6):345–53.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Damodaran, S., Cataland, S.R. (2014). Excessive Bleeding with Normal Prothrombin Time, Partial Thromboplastin Time, and Platelet Count. In: Lichtin, A., Bartholomew, J. (eds) The Coagulation Consult. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9560-4_6
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9560-4_6
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-9559-8
Online ISBN: 978-1-4614-9560-4
eBook Packages: MedicineMedicine (R0)